ArticleHuman gene therapy. Clinical development2013

From bench to bedside: preclinical evaluation of a self-inactivating gammaretroviral vector for the gene therapy of X-linked chronic granulomatous disease.

Stefan Stein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.